236 related articles for article (PubMed ID: 19214145)
1. Comparison of 3 estimation methods of mycophenolic acid AUC based on a limited sampling strategy in renal transplant patients.
Hulin A; Blanchet B; Audard V; Barau C; Furlan V; Durrbach A; Taïeb F; Lang P; Grimbert P; Tod M
Ther Drug Monit; 2009 Apr; 31(2):224-32. PubMed ID: 19214145
[TBL] [Abstract][Full Text] [Related]
2. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
3. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Majchrnak J; Gralak B
J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
[TBL] [Abstract][Full Text] [Related]
4. A possible simplification for the estimation of area under the curve (AUC₀₋₁₂) of enteric-coated mycophenolate sodium in renal transplant patients receiving tacrolimus.
Fleming DH; Mathew BS; Prasanna S; Annapandian VM; John GT
Ther Drug Monit; 2011 Apr; 33(2):165-70. PubMed ID: 21383656
[TBL] [Abstract][Full Text] [Related]
5. Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the concentration time curve in patients receiving concomitant sirolimus or cyclosporine.
Figurski MJ; Nawrocki A; Pescovitz MD; Bouw R; Shaw LM
Ther Drug Monit; 2008 Aug; 30(4):445-55. PubMed ID: 18641543
[TBL] [Abstract][Full Text] [Related]
6. Validation of an abbreviated pharmacokinetic profile for the estimation of mycophenolic acid exposure in pediatric renal transplant recipients.
Weber LT; Hoecker B; Armstrong VW; Oellerich M; Tönshoff B
Ther Drug Monit; 2006 Oct; 28(5):623-31. PubMed ID: 17038876
[TBL] [Abstract][Full Text] [Related]
7. A six-hour extrapolated sampling strategy for monitoring mycophenolic acid in renal transplant patients in the Indian subcontinent.
Fleming DH; Mathew BS; John GT; Chandy SJ; Manivannan J; Jeyaseelan V
J Postgrad Med; 2006; 52(4):248-52. PubMed ID: 17102540
[TBL] [Abstract][Full Text] [Related]
8. Limited sampling strategies for predicting area under the concentration-time curve of mycophenolic acid in islet transplant recipients.
Al-Khatib M; Shapiro RJ; Partovi N; Ting LS; Levine M; Ensom MH
Ann Pharmacother; 2010 Jan; 44(1):19-27. PubMed ID: 19996322
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of mycophenolic acid during the early period after renal transplant.
Nazemian F; Mohammadpur AH; Abtahi B; Naghibi M
Exp Clin Transplant; 2007 Dec; 5(2):658-63. PubMed ID: 18194117
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the mycophenolic acid exposure estimation methods used in the APOMYGERE, FDCC, and Opticept trials.
Barraclough KA; Isbel NM; Staatz CE
Transplantation; 2010 Jul; 90(1):44-51. PubMed ID: 20463644
[TBL] [Abstract][Full Text] [Related]
11. Easy-to-use, accurate and flexible individualized Bayesian limited sampling method without fixed time points for ciclosporin monitoring after liver transplantation.
Langers P; Cremers SC; den Hartigh J; Rijnbeek EM; Ringers J; Lamers CB; van Hoek B
Aliment Pharmacol Ther; 2005 Mar; 21(5):549-57. PubMed ID: 15740538
[TBL] [Abstract][Full Text] [Related]
12. A reliable limited sampling strategy for the estimation of mycophenolic acid area under the concentration time curve in adult renal transplant patients in the stable posttransplant period.
Mathew BS; Fleming DH; Annapandian VM; Prasanna S; Prasanna CG; Chandy SJ; John GT
Ther Drug Monit; 2010 Apr; 32(2):136-40. PubMed ID: 20110849
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of mycophenolic acid and its phenolic-glucuronide and ACYl glucuronide metabolites in stable thoracic transplant recipients.
Ting LS; Partovi N; Levy RD; Riggs KW; Ensom MH
Ther Drug Monit; 2008 Jun; 30(3):282-91. PubMed ID: 18520599
[TBL] [Abstract][Full Text] [Related]
14. The kinetics of mycophenolic acid and its glucuronide metabolite in adult kidney transplant recipients.
Johnson AG; Rigby RJ; Taylor PJ; Jones CE; Allen J; Franzen K; Falk MC; Nicol D
Clin Pharmacol Ther; 1999 Nov; 66(5):492-500. PubMed ID: 10579476
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of enteric-coated mycophenolate sodium: comparative study in patients with autoimmune disease and renal allograft.
Neumann I; Fuhrmann H; Kanzler M; Fang IF; Jaeger A; Graf H; Bayer P; Kovarik J
Expert Opin Pharmacother; 2008 Apr; 9(6):879-86. PubMed ID: 18377332
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of limited sampling strategies for tacrolimus.
Op den Buijsch RA; van de Plas A; Stolk LM; Christiaans MH; van Hooff JP; Undre NA; van Dieijen-Visser MP; Bekers O
Eur J Clin Pharmacol; 2007 Nov; 63(11):1039-44. PubMed ID: 17712551
[TBL] [Abstract][Full Text] [Related]
17. Limited sampling strategy for estimating individual exposure of tacrolimus in pediatric kidney transplant patients.
Zhao W; Fakhoury M; Baudouin V; Maisin A; Deschênes G; Jacqz-Aigrain E
Ther Drug Monit; 2011 Dec; 33(6):681-7. PubMed ID: 22011724
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous estimation of cyclosporin and mycophenolic acid areas under the curve in stable renal transplant patients using a limited sampling strategy.
Le Guellec C; Büchler M; Giraudeau B; Le Meur Y; Gakoué JE; Lebranchu Y; Marquet P; Paintaud G
Eur J Clin Pharmacol; 2002 Jan; 57(11):805-11. PubMed ID: 11868803
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of limited sampling strategies for tacrolimus and mycophenolate in steroid-free renal transplant regimens.
Poulin E; Greanya ED; Partovi N; Shapiro RJ; Al-Khatib M; Ensom MH
Ther Drug Monit; 2011 Feb; 33(1):50-5. PubMed ID: 21157401
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients.
Irtan S; Saint-Marcoux F; Rousseau A; Zhang D; Leroy V; Marquet P; Jacqz-Aigrain E
Ther Drug Monit; 2007 Feb; 29(1):96-102. PubMed ID: 17304156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
